We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current HRMY market cap is 1.69B. The company's latest EPS is USD 2.2698 and P/E is 13.08.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 119.13M | 134.22M | 160.27M | 168.41M | 154.62M |
| Operating Income | 40.42M | 46.9M | 64.36M | 40.2M | 52.03M |
| Net Income | 29.49M | 34.3M | 38.46M | 26.61M | 38.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6M | 159.74M | 305.44M | 437.86M | 582.02M |
| Operating Income | -145.9M | 16.99M | 87.53M | 120.19M | 192.03M |
| Net Income | -187.21M | -63.85M | 34.6M | 181.47M | 128.85M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 715.09M | 760.18M | 777.77M | 811.45M | 846.99M |
| Total Liabilities | 272.05M | 275.01M | 296.43M | 344.46M | 331.59M |
| Total Equity | 443.04M | 485.17M | 481.33M | 466.99M | 515.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 106.7M | 427.07M | 433.44M | 673.87M | 811.45M |
| Total Liabilities | 118.29M | 329.89M | 246.94M | 271.03M | 344.46M |
| Total Equity | -422.86M | 97.18M | 186.51M | 402.84M | 466.99M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 42.56M | 79.07M | 142.72M | 219.39M | 31.14M |
| Investing | -1.79M | -9.56M | -10.37M | -46.44M | -6.19M |
| Financing | 3.41M | 3.07M | -52.03M | -105.55M | -3.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -75.44M | -2.99M | 98.56M | 144.47M | 219.39M |
| Investing | -127.15M | -2M | -100.3M | -141.83M | -46.44M |
| Financing | 143.77M | 209.16M | 7.42M | 6.84M | -105.55M |
| Market Cap | 1.69B |
| Price to Earnings Ratio | 13.08 |
| Price to Sales Ratio | 2.89 |
| Price to Cash Ratio | 5.41 |
| Price to Book Ratio | 3.61 |
| Dividend Yield | - |
| Shares Outstanding | 56.77M |
| Average Volume (1 week) | 318.26k |
| Average Volume (1 Month) | 469.35k |
| 52 Week Change | -18.20% |
| 52 Week High | 39.265 |
| 52 Week Low | 18.6112 |
| Spread (Intraday) | 1.2 (3.91%) |
| Company Name | Harmony Biosciences Holdings Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.harmonybiosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
